MedPath

Nanobio Corporation

Ownership
Private
Employees
-
Market Cap
-
Website

Clinical Trials

7

Active:0
Completed:6

Trial Phases

3 Phases

Phase 1:2
Phase 2:2
Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (7 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (42.9%)
Phase 1
2 (28.6%)
Phase 2
2 (28.6%)

NB-001 Treatment of Recurrent Herpes Labialis

Phase 3
Conditions
Herpes Labialis
Interventions
Drug: Placebo
First Posted Date
2012-09-27
Last Posted Date
2013-06-14
Lead Sponsor
NanoBio Corporation
Target Recruit Count
362
Registration Number
NCT01695187
Locations
🇺🇸

Radiant Research, Inc, Tucson, Arizona, United States

🇺🇸

Radiant Research, Inc. Chicago, Chicago, Illinois, United States

🇺🇸

Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States

and more 5 locations

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008 Administered by Sprayer

Phase 1
Completed
Conditions
Healthy Adult Volunteers
First Posted Date
2011-05-16
Last Posted Date
2013-03-28
Lead Sponsor
NanoBio Corporation
Target Recruit Count
125
Registration Number
NCT01354379
Locations
🇺🇸

Johnson County Clin-Trials, Lenexa, Kansas, United States

Safety and Immunogenicity Study of Inactivated Nasal Influenza Vaccine NB-1008

Phase 1
Completed
Conditions
Healthy Adult Volunteers
First Posted Date
2011-04-12
Last Posted Date
2011-04-12
Lead Sponsor
NanoBio Corporation
Target Recruit Count
199
Registration Number
NCT01333462
Locations
🇺🇸

Johnson County Clin-Trials, Lenexa, Kansas, United States

A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS)

Phase 3
Completed
Conditions
Recurrent Herpes Labialis
Interventions
Drug: Vehicle
First Posted Date
2011-03-29
Last Posted Date
2013-05-23
Lead Sponsor
NanoBio Corporation
Target Recruit Count
847
Registration Number
NCT01324466
Locations
🇺🇸

Radiant Research, Inc., San Antonio, Texas, United States

🇺🇸

Elite Clinical Studies, LLC, Phoenix, Arizona, United States

🇺🇸

Radiant Research, Inc, Pinellas Park, Florida, United States

and more 24 locations

A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis

Phase 3
Completed
Conditions
Recurrent Herpes Simplex Labialis
Interventions
First Posted Date
2011-03-23
Last Posted Date
2013-05-23
Lead Sponsor
NanoBio Corporation
Target Recruit Count
907
Registration Number
NCT01321359
Locations
🇺🇸

Radiant Research, Inc, Greer, South Carolina, United States

🇺🇸

ACR-Phase 1, LLC., Anaheim, California, United States

🇺🇸

Northern California Research, Sacramento, California, United States

and more 27 locations
  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.